• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠癌和直肠癌是两种不同的肿瘤实体吗?建议放弃“结直肠癌”一词。

Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer.

机构信息

Department of General and Visceral Surgery, University Hospital Ulm, 89081 Ulm, Germany.

Research Group Oncology of Gastrointestinal Tumors (FOGT), University of Ulm, 89081 Ulm, Germany.

出版信息

Int J Mol Sci. 2018 Aug 30;19(9):2577. doi: 10.3390/ijms19092577.

DOI:10.3390/ijms19092577
PMID:30200215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6165083/
Abstract

Colon cancer (CC) and rectal cancer (RC) are synonymously called colorectal cancer (CRC). Based on our experience in basic and clinical research as well as routine work in the field, the term CRC should be abandoned. We analyzed the available data from the literature and results from our multicenter Research Group Oncology of Gastrointestinal Tumors termed FOGT to confirm or reject this hypothesis. Anatomically, the risk of developing RC is four times higher than CC, while physical activity helps to prevent CC but not RC. Obvious differences exist in molecular carcinogenesis, pathology, surgical topography and procedures, and multimodal treatment. Therefore, we conclude that CC is not the same as RC. The term "CRC" should no longer be used as a single entity in basic and clinical research as well as other areas of classification.

摘要

结肠癌(CC)和直肠癌(RC)同义地称为结直肠癌(CRC)。根据我们在基础和临床研究以及该领域常规工作中的经验,CRC 这个术语应该被摒弃。我们分析了文献中的可用数据以及我们称之为 FOGT 的胃肠道肿瘤多中心研究小组的结果,以证实或否定这一假设。解剖学上,发展为 RC 的风险是 CC 的四倍,而体力活动有助于预防 CC,但不能预防 RC。在分子发生、病理学、外科解剖和程序以及多模式治疗方面存在明显差异。因此,我们得出结论,CC 与 RC 不同。在基础和临床研究以及其他分类领域,CRC 这个术语不应再作为一个单一实体使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec5/6165083/15b0f44dec56/ijms-19-02577-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec5/6165083/15b0f44dec56/ijms-19-02577-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ec5/6165083/15b0f44dec56/ijms-19-02577-g001.jpg

相似文献

1
Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer.结肠癌和直肠癌是两种不同的肿瘤实体吗?建议放弃“结直肠癌”一词。
Int J Mol Sci. 2018 Aug 30;19(9):2577. doi: 10.3390/ijms19092577.
2
Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark.结直肠癌的报告症状、诊断延迟及分期:丹麦一项基于人群的研究
Colorectal Dis. 2006 Oct;8(8):688-95. doi: 10.1111/j.1463-1318.2006.01014.x.
3
Hand-assisted laparoscopic colon and rectal cancer surgery: feasibility, short-term, and oncological outcomes.手助腹腔镜结直肠肿瘤手术:可行性、近期疗效及肿瘤学结局。
Surgery. 2010 Aug;148(2):378-85. doi: 10.1016/j.surg.2010.05.019.
4
Colon and rectal cancer after renal transplantation.肾移植后结直肠癌
Expert Rev Anticancer Ther. 2008 Aug;8(8):1339-46. doi: 10.1586/14737140.8.8.1339.
5
The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.原发性结肠癌和直肠癌诊断后第二原发性恶性肿瘤的发病特征:一项基于人群的研究。
PLoS One. 2015 Nov 16;10(11):e0143067. doi: 10.1371/journal.pone.0143067. eCollection 2015.
6
Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010.美国 1975-2010 年结肠癌和直肠癌年龄相关发病率的差距日益增大。
JAMA Surg. 2015 Jan;150(1):17-22. doi: 10.1001/jamasurg.2014.1756.
7
miRNAs in colon and rectal cancer: A consensus for their true clinical value.结直肠癌中的 miRNAs:对其真正临床价值的共识。
Clin Chim Acta. 2010 Sep 6;411(17-18):1181-6. doi: 10.1016/j.cca.2010.05.002. Epub 2010 May 7.
8
Rectal and colon cancer: Not just a different anatomic site.直肠癌和结肠癌:不只是不同的解剖部位。
Cancer Treat Rev. 2015 Sep;41(8):671-9. doi: 10.1016/j.ctrv.2015.06.007. Epub 2015 Jun 28.
9
Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study).基于法国人群的结直肠癌家族研究(CCREF研究)对按部位划分的癌症家族相对风险进行估计。
Gut. 2004 Sep;53(9):1322-8. doi: 10.1136/gut.2003.036376.
10
Primary signet ring cell carcinoma of the colon and rectum.结肠和直肠原发性印戒细胞癌
Bull Cancer. 2015 Oct;102(10):880-8. doi: 10.1016/j.bulcan.2015.07.005. Epub 2015 Sep 26.

引用本文的文献

1
Machine learning identifies PYGM as a macrophage polarization-linked metabolic biomarker in rectal cancer prognosis.机器学习将PYGM鉴定为直肠癌预后中与巨噬细胞极化相关的代谢生物标志物。
Front Immunol. 2025 Aug 12;16:1639303. doi: 10.3389/fimmu.2025.1639303. eCollection 2025.
2
Evaluating the influence of the obesity paradox on survival outcomes in patients being treated surgically for rectal cancer-a systematic review and meta-analysis.评估肥胖悖论对接受直肠癌手术治疗患者生存结局的影响——一项系统评价和荟萃分析
Int J Colorectal Dis. 2025 Aug 18;40(1):180. doi: 10.1007/s00384-025-04957-z.
3
Distinctive chromosomal, mutational and transcriptional profiling in colon versus rectal cancers.

本文引用的文献

1
KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer.KRAS 突变与共识分子亚型 2 和 3 独立与结直肠癌免疫浸润和反应性降低相关。
Clin Cancer Res. 2018 Jan 1;24(1):224-233. doi: 10.1158/1078-0432.CCR-17-1090. Epub 2017 Oct 23.
2
[R1 resection in rectal cancer].[直肠癌的R1切除]
Chirurg. 2017 Sep;88(9):771-776. doi: 10.1007/s00104-017-0480-6.
3
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
结肠癌与直肠癌独特的染色体、突变及转录谱分析。
J Transl Med. 2025 Aug 6;23(1):869. doi: 10.1186/s12967-025-06908-2.
4
Antioxidants Acteoside and Orientin as Emerging Agents in Synergistic Cancer Therapy: A Focus on Innovative Applications.抗氧化剂松果菊苷和荭草苷作为协同癌症治疗中的新兴药物:聚焦创新应用
Antioxidants (Basel). 2025 Jul 12;14(7):855. doi: 10.3390/antiox14070855.
5
Non-invasive colorectal cancer biomarkers: HAND2 and GPM6A methylation in circulating tumour DNA.非侵入性结直肠癌生物标志物:循环肿瘤DNA中的HAND2和GPM6A甲基化
Cancer Cell Int. 2025 Jul 18;25(1):269. doi: 10.1186/s12935-025-03898-5.
6
Performance and Prognostic Relevance of Lymph Node Assessment by One-Step Nucleic Acid Amplification Assay in Rectal Cancer: A Multicenter Study.一步核酸扩增检测评估直肠癌淋巴结的性能及预后相关性:一项多中心研究
Cancers (Basel). 2025 Jun 25;17(13):2141. doi: 10.3390/cancers17132141.
7
Minimally invasive converted to open versus upfront open surgeries for rectal cancer: a retrospective cohort study.直肠癌微创转为开放手术与直接开放手术的比较:一项回顾性队列研究。
Surg Endosc. 2025 Aug;39(8):5398-5405. doi: 10.1007/s00464-025-11958-0. Epub 2025 Jul 8.
8
OncoE25: an AI model for predicting postoperative prognosis in early-onset stage I-III colon and rectal cancer-a population-based study using SEER with dual-center cohort validation.OncoE25:一种用于预测早期I-III期结肠癌和直肠癌术后预后的人工智能模型——一项基于人群的研究,使用监测、流行病学和最终结果(SEER)数据库并进行双中心队列验证
J Transl Med. 2025 Jun 22;23(1):695. doi: 10.1186/s12967-025-06663-4.
9
Predicting Early-Onset Colorectal Cancer in Individuals Below Screening Age Using Machine Learning and Real-World Data: Case Control Study.利用机器学习和真实世界数据预测筛查年龄以下个体的早发性结直肠癌:病例对照研究
JMIR Cancer. 2025 Jun 19;11:e64506. doi: 10.2196/64506.
10
Deciphering the role of acetylation-related gene NAT10 in colon cancer progression and immune evasion: implications for overcoming drug resistance.解读乙酰化相关基因NAT10在结肠癌进展和免疫逃逸中的作用:对克服耐药性的启示
Discov Oncol. 2025 May 15;16(1):774. doi: 10.1007/s12672-025-02617-w.
术前放疗的最佳分割和直肠癌手术时机(斯德哥尔摩 III):一项多中心、随机、非盲、III 期、非劣效性试验。
Lancet Oncol. 2017 Mar;18(3):336-346. doi: 10.1016/S1470-2045(17)30086-4. Epub 2017 Feb 10.
4
The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials.原发性肿瘤位置在转移性结直肠癌患者中的相关性:一线临床试验的荟萃分析。
Eur J Cancer. 2017 Jan;70:87-98. doi: 10.1016/j.ejca.2016.10.007. Epub 2016 Nov 29.
5
[Laparoscopic versus open rectal cancer resection: oncologically equal?].[腹腔镜与开腹直肠癌切除术:肿瘤学效果相同吗?]
Chirurg. 2016 Jul;87(7):552-9. doi: 10.1007/s00104-016-0222-1.
6
The consensus molecular subtypes of colorectal cancer.结直肠癌的共识分子亚型
Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12.
7
Stratified Survival Analysis After Adjuvant Chemotherapy of Colon Cancer Reveals a Benefit for Older Patients.结肠癌辅助化疗后的分层生存分析显示老年患者获益。
Anticancer Res. 2015 Oct;35(10):5587-93.
8
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.奥沙利铂联合氟尿嘧啶为基础的术前放化疗和局部进展期直肠癌术后化疗(德国 CAO/ARO/AIO-04 研究):多中心、开放标签、随机、III 期临床试验的最终结果。
Lancet Oncol. 2015 Aug;16(8):979-89. doi: 10.1016/S1470-2045(15)00159-X. Epub 2015 Jul 15.
9
Quality of Life After Sphincter-Preserving Rectal Cancer Resection.保留括约肌直肠癌切除术后的生活质量
Clin Colorectal Cancer. 2015 Dec;14(4):e33-40. doi: 10.1016/j.clcc.2015.05.012. Epub 2015 Jun 6.
10
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.奥沙利铂、氟尿嘧啶和亚叶酸钙与氟尿嘧啶和亚叶酸钙作为术前放化疗后局部进展期直肠癌的辅助化疗(ADORE):一项开放标签、多中心、2 期、随机对照临床试验。
Lancet Oncol. 2014 Oct;15(11):1245-53. doi: 10.1016/S1470-2045(14)70377-8. Epub 2014 Sep 4.